May 2005
Volume 46, Issue 13
ARVO Annual Meeting Abstract  |   May 2005
Thymosin Beta 4 Inhibits Benzalkonium Chloride–Mediated Apoptosis of Human Corneal Epithelial Cells in vitro
Author Affiliations & Notes
  • G. Sosne
    Ophthalmology and Anatomy/Cell Biology,
    Wayne State University, Detroit, MI
  • A.–R. Albeiruti
    Anatomy/Cell Biology,
    Wayne State University, Detroit, MI
  • B. Hollis
    Anatomy/Cell Biology,
    Wayne State University, Detroit, MI
  • M. Kurpakus–Wheater
    3Department of Biomedical Sciences, School of Dentistry, University of Detroit Mercy, Detroit, MI
  • Footnotes
    Commercial Relationships  G. Sosne, None; A. Albeiruti, None; B. Hollis, None; M. Kurpakus–Wheater, None.
  • Footnotes
    Support  NIH Grant EY13412, Career Development Award Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 885. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G. Sosne, A.–R. Albeiruti, B. Hollis, M. Kurpakus–Wheater; Thymosin Beta 4 Inhibits Benzalkonium Chloride–Mediated Apoptosis of Human Corneal Epithelial Cells in vitro . Invest. Ophthalmol. Vis. Sci. 2005;46(13):885.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: Thymosin beta 4 (Tß4), a 43 amino acid molecule, promotes ocular wound healing, decreases ocular inflammation, and has anti–apoptotic effects on corneal epithelium. In this study, the effect of Tß4 on the survival of cultured human corneal epithelial cells exposed to benzalkonium chloride (BAK) was measured. Methods: Human corneal epithelial cells at approximately 80% confluence were treated with 0%, 0.001%, 0.01%, or 0.1% BAK for 15 minutes. After 3 and 24 hours of recovery in culture medium, cell proliferation was measured using a colorimetric BrdU incorporation assay. Apoptosis was measured using a colorimetric annexin–based cell death assay. Studies were repeated in the presence of 1 µg/ml Tß4, an in vitro dosage demonstrated effective in several published studies. To further assess the ability of Tß4 to prevent apoptosis, corneal epithelial cells were treated with 0.01% BAK +4 over a 5 day time course. Results: At all BAK concentrations used, corneal epithelial cell proliferation was inhibited, and apoptosis was increased, compared to control at 3 and 24 hours recovery time. At the 3 and 24 hour time points, Tß4 did not abrogate the deleterious effects of BAK; cell proliferation was not promoted by Tß4 and apoptosis was not inhibited. However, at longer times in culture (2 to 5 days), Tß4 treatment significantly inhibited the BAK–initiated epithelial cell apoptosis. In addition, Tß4–treated cells demonstrated decreased apoptosis compared to those cultured in medium alone for 5 days. Conclusions: BAK, a preservative used in many commercially available ocular solutions, induces corneal epithelial cell apoptosis in culture, suggesting that long–term exposure is deleterious to corneal health. The study reported here suggests that Tß4 may be able to overcome the deleterious pro–apoptotic effects of BAK. Since many BAK–containing eye drops are typically used for extended periods of time, Tß4 may be a useful additive to solutions containing this preservative.

Keywords: apoptosis/cell death • cell death/apoptosis • cornea: epithelium 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.